Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$841.65

3.44 (0.41%)

, GOOGL

Alphabet Class A

$860.08

3.57 (0.42%)

06:17
04/21/17
04/21
06:17
04/21/17
06:17

Ad, tech companies discuss ad blocking solutions, Ad Age reports

Advertising and tech companies are in discussions to implement ad blocking that would prevent browsers such as Google (GOOG, GOOGL) Chrome and Microsoft (MSFT) Edge from displaying ads which weaken the consumer experience, Advertising Age reports, citing comments made by Stu Ingis, counsel to the Coalition for Better Ads and attorney at Venable. The discussions are taking place among members of the coalition including Google, Microsoft, Procter & Gamble (PG), Unilever (UL, UN), WPP's ad-buying giant GroupM, Facebook (FB), Thomson Reuters (TRI), The Washington Post, the Interactive Advertising Bureau and the Association of National Advertisers. The companies expect to have a "blocking mechanism in place before the end of this year, Ingis predicted," according to Ad Age. Reference Link

GOOG

Alphabet

$841.65

3.44 (0.41%)

GOOGL

Alphabet Class A

$860.08

3.57 (0.42%)

MSFT

Microsoft

$65.50

0.46 (0.71%)

PG

Procter & Gamble

$89.33

-0.27 (-0.30%)

UL

Unilever; also tag UN

$50.44

0.23 (0.46%)

UN

Unilever; also tag UL

$51.14

0.15 (0.29%)

FB

Facebook

$143.80

1.53 (1.08%)

TRI

Thomson Reuters

$42.74

-0.61 (-1.41%)

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 03

    May

  • 09

    May

  • 22

    May

GOOG Alphabet
$841.65

3.44 (0.41%)

04/17/17
FBCO
04/17/17
NO CHANGE
Target $1100
FBCO
Outperform
Credit Suisse remains bullish on Alphabet ahead of Q1 results
Credit Suisse analyst Stephen Ju notes that Alphabet's shares have underperformed relative to its Internet large cap peers in 2016 and 2017 year to date. Nonetheless, he points out that even as the sheer size of its search business continues to blunt the contributions from other businesses, YouTube, Play, and Cloud collectively should be contributing about 1/3 of Net Revenue within three years. Further, the analyst anticipates free cash flow to grow at about 17.5% CAGR over the next five years, and therefore argues that Alphabet Class A shares should trade higher. Ju reiterates an Outperform rating and $1100 price target on the shares.
04/13/17
COWN
04/13/17
NO CHANGE
Target $60
COWN
Outperform
Criteo price target raised to $60 from $55 at Cowen
Cowen analyst Thomas Champion raised his price target on Criteo (CRTO) to $60 from $55 as he believes the company is well positioned in the near term given recent AdTech moves by Facebook (FB) and Alphabet (GOOG). He sees header bidding adoption as opening more inventory and sees the long-term potential for more competition. Champion raised his estimates to account for the seasonal impact in revenues versus more linear growth in expenses while reiterating his Outperform rating on Criteo shares.
04/12/17
JMPS
04/12/17
NO CHANGE
JMPS
MINDBODY partnership positive, says JMP Securities
JMP Securities analyst Patrick Walravens says that MINDBODY's (MB) partnership with Google (GOOG, GOOGL) will enable MINDBODY's subscribers "to use dynamic pricing," and allow the company to increase its revenue by charging subscribers "a 10% fee for the booking and a 1% fee for the payment processing." The analyst keeps a $32 price target and an Outperform rating on MINDBODY.
04/11/17
04/11/17
UPGRADE
Target $43

Overweight
Yelp upgraded to Overweight on 'underappreciated core' at Pacific Crest
As previously reported, Pacific Crest analyst Brad Erickson upgraded Yelp (YELP) to Overweight from Sector Weight, saying his checks with local ad customers indicate Yelp's core franchise is healthy and appears insulated from larger competitors like Google (GOOG) and Facebook (FB). Over $60B of offline local ad spending is shifting toward online and Yelp remains well-positioned to capitalize on this trend, though its core business is underappreciated in the shares' current value, said Erickson, who has a $43 price target on the stock.
GOOGL Alphabet Class A
$860.08

3.57 (0.42%)

04/20/17
PACS
04/20/17
NO CHANGE
PACS
Alphabet checks positive, says Pacific Crest
Checks with advertisers indicate that "search remains very strong" for Alphabet, while advertisers' feedback on YouTube "remained very positive," according to Pacific Crest analyst Andy Hargreaves. He keeps a $1,040 price target on the shares and recommends buying the stock.
MSFT Microsoft
$65.50

0.46 (0.71%)

04/13/17
RBCM
04/13/17
NO CHANGE
RBCM
Microsoft Q4 guidance likely to rise, says RBC Capital
RBC Capital expects Microsoft's Q4 guidance to improve, "driven by improving transactional business, good commercial cloud gross margins and modestly better PC data."
03/17/17
PACS
03/17/17
NO CHANGE
PACS
Feedback on Microsoft cloud more positive, says Pacific Crest
Microsoft's (MSFT) cloud partners have become more upbeat on the company's cloud business, Azure, according to Pacific Crest analyst Brent Bracelin. The analyst says that Azure has "become a viable alternative to" Amazon's (AMZN) AWS. He continues to recommend buying Microsoft stock. .
03/17/17
PACS
03/17/17
NO CHANGE
PACS
Growth of Amazon.com cloud business could moderate, says Pacific Crest
Pacific Crest analyst Brent Bracelin says that heavy investments by Microsoft (MSFT) and Google (GOOG, GOOGL) could make their cloud businesses more competitive with Amazon's (AMZN) AWS. The analyst says that AWS' growth could decelerate this year and in 2018. He lowered his estimates for Amazon and cut his price target on the name to $895 from $905 but keeps an Overweight rating on the shares.
03/20/17
JMPS
03/20/17
NO CHANGE
JMPS
Tableau weakness creates buying opportunity, says JMP Securities
JMP Securities analyst Greg McDowell says that investors' worries about Tableau's (DATA) intensifying competition are overdone. The analyst thinks that the company has a significant lead over its competitions, while many enterprises are starting to use analytics. The analyst adds that, although Microsoft (MSFT) has become a tougher competitor, the competition from Qlik and TIBCO Sportfire has eased. The analyst says that the weakness in Tableau's stock has created a buying opportunity, and he keeps a $65 price target and an Outperform rating on Tableau.
PG Procter & Gamble
$89.33

-0.27 (-0.30%)

03/06/17
RILY
03/06/17
DOWNGRADE
Target $91
RILY
Neutral
Procter & Gamble downgraded to Neutral from Buy at B. Riley
B. Riley analyst Linda Bolton Weiser downgraded Procter & Gamble to Neutral saying that while the stock is up 11% from the December low, the company's fundamentals have weakened. The analyst cut her price target for the shares to $91 from $106.
03/21/17
JPMS
03/21/17
INITIATION
Target $98
JPMS
Neutral
Procter & Gamble initiated with a Neutral at JPMorgan
JPMorgan analyst Andrea Teixeira started Procter & Gamble with a Neutral rating and $98 price target.
03/06/17
03/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. MetLife (MET) downgraded to Neutral from Buy at BofA/Merrill with analyst Seth Weiss saying shares are now trading above the level of the disappointing fourth quarter earnings report and prefers Prudential (PRU) given it benefits more from improving interest rates and easing regulations. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at B. Riley with analyst Linda Bolton Weiser saying that while the stock is up 11% from the December low, the company's fundamentals have weakened. The analyst cut her price target for the shares to $91 from $106. 3. GoPro (GPRO) downgraded to Sell from Neutral at Goldman with analyst Simona Jankowski saying the company faces "significant challenges" amid camera market saturation, product rollout issues in the holiday season, and a disappointing entry into the drone market. The analyst sees risk to consensus estimates and views the stock as overvalued. 4. Hawaiian Electric (HE) downgraded to Underperform from In Line at Evercore ISI with analyst Greg Gordon saying he believes the risk/return for shares is skewed to the downside and estimates a "significantly lower total return" compared to other utilities he covers. He maintains a $31 price target on Hawaiian Electric shares. 5. Akorn (AKRX) downgraded to Hold from Buy at Deutsche Bank with analyst Gregg Gilbert saying the risk/reward is more balanced following the recent rally in the shares. Upside from current levels will have more to do with the "hard-to-call dynamics of new product approvals vs. base business erosion," Gilbert tells investors in a research note. He cut his price target for the shares to $24 from $28. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/27/17
RBCM
02/27/17
NO CHANGE
RBCM
Edgewell Personal Care should be bought at current levels, says RBC Capital
RBC Capital analyst Nik Modi says that Edgewell's stock has underperformed the market by about 9% since Procter & Gamble (PG) announced that it would lower the prices of its U.S. blades/razor business as of April 1. The analyst says that the market may be overestimating the ultimate impact of the price cuts on Edgewell. Modi recommends buying Edgewell at current levels and keeps a $105 price target on the name.
UL Unilever; also tag UN
$50.44

0.23 (0.46%)

04/12/17
SUSQ
04/12/17
UPGRADE
Target $132
SUSQ
Positive
PepsiCo upgraded to Positive on M&A potential at Susquehanna
As previously reported, Susquehanna analyst Pablo Zuanic upgraded PepsiCo to Positive from Neutral. He believes Kraft Heinz (KHC) needs to a do another deal following its failed acquisition of Unilever (UL) and feels Pepsi and Mondelez (MDLZ) are the two most likely candidates. Zuanic raised his price target to $132 form $118 on PepsiCo shares.
03/03/17
SBSH
03/03/17
NO CHANGE
SBSH
Kraft may look at General Mills, Kellogg, says Citi
In the wake of Kraft Heinz's (KHC) bid for Unilever (UN), Citi analyst Adam Spielman weighed in on the implications for consumer staples globally and said he thinks further M&A is likely, most probably in the U.S. He believes Kraft may still look at Unilever's food assets, or could target General Mills (GIS) or Kellogg (K). He also sees Mondelez (MDLZ) as a possible, but less likely, target for Kraft. Unilever could react by entering new categories, but Spielman sees it as more likely to reinforce existing strengths, "which points to" Colgate (CL) or Edgewell (EPC), he tells investors.
03/31/17
ABNA
03/31/17
DOWNGRADE
ABNA
Sell
Unilever downgraded to Sell from Hold at ABN Amro
03/24/17
LEHM
03/24/17
UPGRADE
LEHM
Overweight
Unilever upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Alex Smith upgraded Unilever to Overweight saying the company is among the best positioned staples companies to benefit from" emerging market category development." The analyst also expects Unilever to expand its ZBB initiatives to more mature categories, leading to higher margin guidance. Smith raised his price target for the shares to EUR 50.40.
UN Unilever; also tag UL
$51.14

0.15 (0.29%)

FB Facebook
$143.80

1.53 (1.08%)

04/17/17
JEFF
04/17/17
NO CHANGE
Target $30
JEFF
Buy
Jefferies sees potential upside to Snap's Q1 results after survey
After surveying 1,000 internet users in the U.S. aged 18-45 who use both Facebook (FB) and Snap's (SNAP) Snapchat, Jefferies analyst Brian Fitzgerald believes there could be upside to Snap's Q1 results. The survey found that both Instagram and Snapchat are seeing continued user growth, with Snapchat usage growing fastest among the older demographic, Fitzgerald tells investors in a research note. The analyst also believes Snap's recent improvements to targeting and the increase gamified ad formats will help drive average revenue per user growth over time. Fitzgerald keeps a Buy rating on Snap with a $30 price target. The stock closed Thursday down 1c to $20.19.
04/17/17
FBCO
04/17/17
NO CHANGE
Target $175
FBCO
Outperform
Facebook price target raised to $175 from $170 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Facebook to $175 from $170 ahead of Q1 results, and as he increases his ad volume growth estimates for 2H17 from what he felt was "an excessively conservative" level, offset by higher anticipated content spend. The analyst reiterates an Outperform rating on the shares.
04/17/17
AGIS
04/17/17
NO CHANGE
Target $160
AGIS
Buy
Facebook price target raised to $160 ahead of F8, earnings at Aegis
Aegis analyst Victor Anthony said he expects Facebook's annual "F8" developer conference this week and the company's Q1 earnings report on May 3 to both be catalysts for the stock and raised his price target on the shares to $160 from $155 ahead of the events. He expects F8 to focus on innovations with the camera and video and he predicts the company will report solid quarterly results given strong advertiser checks. Anthony keeps a Buy rating on Facebook shares.
04/19/17
MSCN
04/19/17
NO CHANGE
MSCN
Facebook overall trends remain 'very strong,' says MScience
MScience analyst Steven Weinstein is forecasting Facebook's North American revenues of 4.07B, down slightly from $4.08B, above consensus of $4.005B. The analyst said slowing increases in US spending per advertiser led to a modest deceleration in revenue growth, but these trends are reflected in management's comments regarding ad load leveling off. Weinstein views overall trends as "very strong."
TRI Thomson Reuters
$42.74

-0.61 (-1.41%)

11/03/16
11/03/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BioMarin (BMRN) initiated with a Buy at Deutsche Bank. 2. Ambev (ABEV) reinstated with an Equal Weight at Barclays. 3. ARIAD (ARIA) initiated with a Hold at Deutsche Bank. 4. Thomson Reuters (TRI) reinstated with a Neutral at JPMorgan. 5. Exelixis (EXEL) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage click here.
04/20/17
BREN
04/20/17
INITIATION
Target $37
BREN
Sell
Thomson Reuters initiated with a Sell at Berenberg
Berenberg analyst Alastair Reid started Thomson Reuters with a Sell rating and $37 price target.
04/20/17
04/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MSG (MSG)resumed with Overweight, target upped to $245 at JPMorgan. 2. Thomson Reuters (TRI) initiated with a Sell at Berenberg. 3. ServiceMaster (SERV) initiated with an Overweight at JPMorgan. 4. Warrior Met Coal (HCC) initiated with a Market Perform at FBR Capital. 5. TransGlobe (TGA) resumed with a Speculative Buy at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/12/16
NATB
12/12/16
DOWNGRADE
NATB
Sector Perform
Thomson Reuters downgraded to Sector Perform from Outperform at National Bank

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.